Skip to main content
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES — Investor Relations & Filings

Ticker · ABT ISIN · US0028241000 LEI · HQD377W2YR662HK5JX27 US Manufacturing
Filings indexed 4,256 across all filing types
Latest filing 2016-06-27 Regulatory Filings
Country US United States of America
Listing US ABT

About ABBOTT LABORATORIES

https://www.abbott.com

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Recent filings

Filing Released Lang Actions
Abbott Laboratories Files Form 11-K
Regulatory Filings
2016-06-27 English
11-K
Annual Report Classification · 95% confidence The document is a Form 11-K filed with the U.S. Securities and Exchange Commission, which is an annual report for employee stock purchase, savings, and similar plans. It includes detailed financial statements, an independent auditor's report, notes to financial statements, and supplemental schedules for the Abbott Laboratories Stock Retirement Plan for the fiscal year ended December 31, 2015. The presence of comprehensive financial data and audit opinion confirms this is the actual annual report for the employee benefit plan, not just an announcement or certification. Therefore, the correct classification is 'Annual Report' with the specific SEC form code 11-K, which corresponds to the filing type code '10-K' in the provided taxonomy for official yearly reports covering company activity and full financial performance, including employee benefit plans.
2016-06-24 English
FORM 4 -
Director's Dealing
2016-06-17 English
FORM 4 -
Director's Dealing
2016-06-17 English
Statement of changes in Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'SEC FORM 4' and is a 'Statement of Changes in Beneficial Ownership' filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. It details transactions by an officer/director (Senior Vice President) of Abbott Laboratories, including dates, amounts, and types of securities acquired or disposed of. This form is specifically used to report insider transactions by company directors and executives. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives. The document is not an annual report, earnings release, or any other type of financial or regulatory filing but specifically a Form 4 insider transaction report.
2016-06-17 English
Statement of changes in Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of company securities by insiders such as officers or directors. It details transactions in the company's shares by a senior vice president, including dates, amounts, and transaction types. This type of filing is specifically used to report insider trades and changes in ownership by company executives or directors. It is not an annual report, earnings release, or any other financial or governance report. Therefore, it fits the category of Director's Dealing filings.
2016-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.